Gregory Scott Duncan
CHIEF EXECUTIVE OFFICER at Dogwood Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: CorMedix Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CorMedix Inc. June 23, 202694.3%
-
Dogwood Therapeutics Inc. June 16, 2026100.0%
-
CorMedix Inc. June 24, 202595.2%
-
Dogwood Therapeutics Inc. June 18, 202599.0%
-
CorMedix Inc. November 21, 202498.4%
-
Dogwood Therapeutics Inc. June 18, 202493.4%
-
CorMedix Inc. October 26, 202392.9%
-
Dogwood Therapeutics Inc. June 15, 202398.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 26, 2026 | CorMedix Inc. | Grant or award | +30,453 | — | — |
| Sep 16, 2025 | CorMedix Inc. | Option exercise | +13,333 | $8.32 | $110,931 |
| Jan 17, 2025 | CorMedix Inc. | Grant or award | +25,000 | — | — |
| Aug 17, 2023 | Dogwood Therapeutics Inc. | Open-market purchase | +25,000 | $1.25 | $31,250 |
Questions about Gregory Scott Duncan
What boards is Gregory Scott Duncan on?
Gregory Scott Duncan sits on the boards of CorMedix Inc. and Dogwood Therapeutics Inc.
What company is Gregory Scott Duncan the CEO of?
Gregory Scott Duncan is CHIEF EXECUTIVE OFFICER of Dogwood Therapeutics Inc.
How long has Gregory Scott Duncan served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.